Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvation Bio Inc.CL A(NUVB) | 15,072,340 | 14,072,340 | -1,000,000 | $22.76M | $51.22M | 33.05% | +$28.46M |
| Lexeo Therapeutics, Inc.(LXEO) | 2,157,623 | 2,355,904 | +198,281 | $28.96M | $36.94M | 23.83% | +$7.99M |
| Replimune Group, Inc.(REPL) | 3,001,319 | 3,001,319 | 0 | $25.30M | $24.52M | 15.82% | -$780.3K |
| enGene Holdings Inc. COM | 1,131,175 | 1,076,357 | -54,818 | $10.44M | $18.24M | 11.77% | +$7.80M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $3.44M | $8.44M | 5.44% | +$5.00M |
| Morphic Holding | 309,846 | 159,846 | -150,000 | $8.95M | $5.63M | 3.63% | -$3.32M |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | $4.43M | $3.19M | 2.06% | -$1.24M |
| Immunic, Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | $2.68M | $2.36M | 1.52% | -$321.9K |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 475,077 | 360,903 | -114,174 | $403.8K | $1.88M | 1.21% | +$1.47M |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | $1.96M | $1.34M | 0.87% | -$613.1K |
| Kronos Bio | 3,818,283 | 955,866 | -2,862,417 | $4.77M | $1.24M | 0.80% | -$3.53M |
| Senti Biosciences, Inc. | 195,792 | 0 | -195,792 | $129.2K | $0 | — | -$129.2K |
| Spruce Biosciences | 2,161,022 | 0 | -2,161,022 | $6.33M | $0 | — | -$6.33M |
| Theseus Pharmaceuticals | 711,479 | 0 | -711,479 | $2.88M | $0 | — | -$2.88M |